Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Robert S Langer Insider Profile
4 Followers
Robert S Langer, Director at PureTech Health, holds 2.94M shares in PureTech Health (Ticker: GB:PRTC). Most recently, Robert S Langer Bought 4,300p shares of PureTech Health on Mar 14, 2018 for an estimated value of 6.97K.
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+8.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Robert S Langer's holdings
Insider Roles
Director
Roles that Robert S Langer holds in companies
Most Profitable Insider Trade
The most profitable trade made by Robert S Langer
Robert S Langer's Trading History
List of latest transactions for each holding click on a transaction to see Robert S Langer's performance on stock
You May Also Like
Robert S Langer insider profile FAQ
What is the percentage of profitable transactions made by Robert S Langer?
The percentage of profitable transactions made by Robert S Langer is 100%.
What is the average return per transaction made by Robert S Langer?
The average return per transaction made by Robert S Langer is 8.80%.
What stocks does Robert S Langer hold?
Robert S Langer holds: GB:PRTC stocks.
What was Robert S Langer’s latest transaction?
Robert S Langer latest transaction was an Informative Buy of 6.97K.
What was Robert S Langer's most profitable transaction?
Robert S Langer’s most profitable transaction was an Informative Buy of GB:PRTC stock on September 28, 2015. The return on the trade was 17.30%.
What is Robert S Langer's role in PureTech Health?
Robert S Langer's role in PureTech Health is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.